Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine therapy and lipid profile in adults with subclinical hypothyroidism
IRCT20260622069921N1Phase 3Completed
- Sponsor
- Continental Hospitals
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Continental Hospitals. Primary endpoints: Mean change in total serum cholesterol, Mean change in serum low density lipoproteins and 2 more. Started Mar 2025; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20260622069921N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260622069921N1.